Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588339518> ?p ?o ?g. }
- W2588339518 endingPage "662" @default.
- W2588339518 startingPage "652" @default.
- W2588339518 abstract "Abstract Objectives Oxethazaine (OXZ) is one of the few local anaesthetics that provides analgesia at low pH, but presents poor solubility, cytotoxicity and no parenteral formulations. To address these issues, we aimed to prepare OXZ host-guest inclusion complex with hydroxypropyl-beta-cyclodextrin (HP-β-CD). Methods The inclusion complex was formed by co-solubilization, followed by a job plot analysis to determine stoichiometry of complexation and dialysis equilibrium analysis (based on UV/VIS absorption and fluorescence profiles of OXZ). Complex formation was confirmed by phase-solubility data, X-ray, Scanning Electron Microscopy and DOSY-1H-NMR experiments. In vitro cytotoxicity was analysed by MTT test in 3T3 fibroblasts. In vivo analgesia was tested by Von Frey test (inflammatory wounds – rats). Key findings Oxethazaine complexed (1 : 1 molar ratio) with HP-β-CD, as indicated by loss of OZX crystalline structure (X-ray) and strong host: guest interaction (NMR, K = 198/m), besides increased solubility. In vitro cell survival improved with the complex (IC50 OXZ = 28.9 μm, OXZ : HP-β-CD = 57.8 μm). In addition, the complex (0.1% OXZ) promoted in vivo analgesia for the same time that 2% lidocaine/epinephrine did. Conclusion Our results show that complexation improved physicochemical and biological properties of OXZ, allowing its application to inflamed tissues by parenteral routes." @default.
- W2588339518 created "2017-02-24" @default.
- W2588339518 creator A5033583068 @default.
- W2588339518 creator A5042607942 @default.
- W2588339518 creator A5047521279 @default.
- W2588339518 creator A5060396929 @default.
- W2588339518 creator A5069694528 @default.
- W2588339518 creator A5077139192 @default.
- W2588339518 creator A5079721766 @default.
- W2588339518 creator A5080007124 @default.
- W2588339518 creator A5085172832 @default.
- W2588339518 date "2017-02-17" @default.
- W2588339518 modified "2023-10-01" @default.
- W2588339518 title "Complexation of oxethazaine with 2-hydroxypropyl-β-cyclodextrin: increased drug solubility, decreased cytotoxicity and analgesia at inflamed tissues" @default.
- W2588339518 cites W1487016013 @default.
- W2588339518 cites W1521455215 @default.
- W2588339518 cites W1564577751 @default.
- W2588339518 cites W1629179716 @default.
- W2588339518 cites W1980086284 @default.
- W2588339518 cites W1984805687 @default.
- W2588339518 cites W1994925796 @default.
- W2588339518 cites W1996121243 @default.
- W2588339518 cites W1996424997 @default.
- W2588339518 cites W1999858837 @default.
- W2588339518 cites W2001570423 @default.
- W2588339518 cites W2012682096 @default.
- W2588339518 cites W2012931837 @default.
- W2588339518 cites W2017281141 @default.
- W2588339518 cites W2026257417 @default.
- W2588339518 cites W2042211625 @default.
- W2588339518 cites W2042373769 @default.
- W2588339518 cites W2044609602 @default.
- W2588339518 cites W2044932064 @default.
- W2588339518 cites W2046086288 @default.
- W2588339518 cites W2072968157 @default.
- W2588339518 cites W2077095694 @default.
- W2588339518 cites W2085592625 @default.
- W2588339518 cites W2086301793 @default.
- W2588339518 cites W2087454739 @default.
- W2588339518 cites W2088323113 @default.
- W2588339518 cites W2090255004 @default.
- W2588339518 cites W2091550009 @default.
- W2588339518 cites W2109665466 @default.
- W2588339518 cites W2112758044 @default.
- W2588339518 cites W2114918609 @default.
- W2588339518 cites W2133061394 @default.
- W2588339518 cites W2149714082 @default.
- W2588339518 cites W2156400710 @default.
- W2588339518 cites W2263270202 @default.
- W2588339518 cites W2333564858 @default.
- W2588339518 cites W2414764273 @default.
- W2588339518 cites W4210948946 @default.
- W2588339518 cites W4243745146 @default.
- W2588339518 cites W84774888 @default.
- W2588339518 doi "https://doi.org/10.1111/jphp.12703" @default.
- W2588339518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28211640" @default.
- W2588339518 hasPublicationYear "2017" @default.
- W2588339518 type Work @default.
- W2588339518 sameAs 2588339518 @default.
- W2588339518 citedByCount "15" @default.
- W2588339518 countsByYear W25883395182018 @default.
- W2588339518 countsByYear W25883395182019 @default.
- W2588339518 countsByYear W25883395182020 @default.
- W2588339518 countsByYear W25883395182021 @default.
- W2588339518 countsByYear W25883395182022 @default.
- W2588339518 countsByYear W25883395182023 @default.
- W2588339518 crossrefType "journal-article" @default.
- W2588339518 hasAuthorship W2588339518A5033583068 @default.
- W2588339518 hasAuthorship W2588339518A5042607942 @default.
- W2588339518 hasAuthorship W2588339518A5047521279 @default.
- W2588339518 hasAuthorship W2588339518A5060396929 @default.
- W2588339518 hasAuthorship W2588339518A5069694528 @default.
- W2588339518 hasAuthorship W2588339518A5077139192 @default.
- W2588339518 hasAuthorship W2588339518A5079721766 @default.
- W2588339518 hasAuthorship W2588339518A5080007124 @default.
- W2588339518 hasAuthorship W2588339518A5085172832 @default.
- W2588339518 hasConcept C103319777 @default.
- W2588339518 hasConcept C109316439 @default.
- W2588339518 hasConcept C125287762 @default.
- W2588339518 hasConcept C13965031 @default.
- W2588339518 hasConcept C150903083 @default.
- W2588339518 hasConcept C155574463 @default.
- W2588339518 hasConcept C159985019 @default.
- W2588339518 hasConcept C178790620 @default.
- W2588339518 hasConcept C185592680 @default.
- W2588339518 hasConcept C192562407 @default.
- W2588339518 hasConcept C202751555 @default.
- W2588339518 hasConcept C207001950 @default.
- W2588339518 hasConcept C2779433975 @default.
- W2588339518 hasConcept C43617362 @default.
- W2588339518 hasConcept C55493867 @default.
- W2588339518 hasConcept C71240020 @default.
- W2588339518 hasConcept C86803240 @default.
- W2588339518 hasConceptScore W2588339518C103319777 @default.
- W2588339518 hasConceptScore W2588339518C109316439 @default.
- W2588339518 hasConceptScore W2588339518C125287762 @default.
- W2588339518 hasConceptScore W2588339518C13965031 @default.
- W2588339518 hasConceptScore W2588339518C150903083 @default.